{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T18:15:35Z","timestamp":1715969735033},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1097\/mca.0000000000000688","type":"journal-article","created":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T22:51:09Z","timestamp":1544568669000},"page":"143-149","source":"Crossref","is-referenced-by-count":1,"title":["Outcomes of patients with and without baseline lipid-lowering therapy undergoing revascularization for left main coronary artery disease"],"prefix":"10.1097","volume":"30","author":[{"given":"Shmuel","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Redfors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Vrolix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Macaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ori","family":"Ben-Yehuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arie Pieter","family":"Kappetein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph F.","family":"Sabik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick W.","family":"Serruys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210204","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1161\/01.CIR.91.9.2488","article-title":"Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics","volume":"91","author":"Berliner","year":"1995","journal-title":"Circulation"},{"key":"R2-11-20210204","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jacc.2014.05.015","article-title":"Review of clinical practice guidelines for the management of LDL-related risk","volume":"64","author":"Morris","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R3-11-20210204","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"key":"R4-11-20210204","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/archinte.158.11.1253","article-title":"Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the Hyperlipidemias","volume":"158","author":"Buchwald","year":"1998","journal-title":"Arch Intern Med"},{"key":"R5-11-20210204","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1016\/j.jacc.2013.11.003","article-title":"2013 AHAACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of CardiologyAmerican Heart Association Task Force on Practice Guidelines.","volume":"63","author":"Eckel","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R6-11-20210204","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"R7-11-20210204","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/01.CIR.103.7.926","article-title":"Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization","volume":"103","author":"Crisby","year":"2001","journal-title":"Circulation"},{"key":"R8-11-20210204","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/hq1101.098486","article-title":"Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors","volume":"21","author":"Takemoto","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R9-11-20210204","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1161\/01.ATV.0000032033.39301.6A","article-title":"Statin therapy in acute coronary syndromes: mechanistic insight into clinical benefit","volume":"22","author":"Sposito","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R10-11-20210204","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"R11-11-20210204","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1056\/NEJMoa1610227","article-title":"Everolimus-eluting stents or bypass surgery for left main coronary artery disease","volume":"375","author":"Stone","year":"2016","journal-title":"N Engl J Med"},{"key":"R12-11-20210204","doi-asserted-by":"crossref","first-page":"861","DOI":"10.4244\/EIJV12I7A141","article-title":"Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial","volume":"12","author":"Kappetein","year":"2016","journal-title":"EuroIntervention"},{"key":"R13-11-20210204","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa0804626","article-title":"Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease","volume":"360","author":"Serruys","year":"2009","journal-title":"N Engl J Med"},{"key":"R14-11-20210204","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa042000","article-title":"Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease","volume":"352","author":"Nissen","year":"2005","journal-title":"N Engl J Med"},{"key":"R15-11-20210204","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jacc.2009.04.033","article-title":"Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study)","volume":"54","author":"Hiro","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R16-11-20210204","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/CIRCGENETICS.111.961144","article-title":"Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial","volume":"5","author":"Chasman","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"R17-11-20210204","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ahj.2004.12.008","article-title":"Relationship of a comprehensive panel of plasma oxidized low-density lipoprotein markers to angiographic restenosis in patients undergoing percutaneous coronary intervention for stable angina","volume":"150","author":"Segev","year":"2005","journal-title":"Am Heart J"},{"key":"R18-11-20210204","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ahj.2004.10.008","article-title":"Lack of association between circulating levels of plasma oxidized low-density lipoproteins and clinical outcome after coronary stenting","volume":"150","author":"Braun","year":"2005","journal-title":"Am Heart J"},{"key":"R19-11-20210204","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/euhj.1998.1150","article-title":"A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial","volume":"20","author":"Serruys","year":"1999","journal-title":"Eur Heart J"},{"key":"R20-11-20210204","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0735-1097(02)02597-4","article-title":"Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials","volume":"40","author":"Cutlip","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R21-11-20210204","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0735-1097(94)00341-M","article-title":"Relation of saphenous vein graft obstruction to serum cholesterol levels","volume":"25","author":"Daida","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"R22-11-20210204","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0735-1097(99)00526-4","article-title":"Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury","volume":"35","author":"Indolfi","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R23-11-20210204","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/HCO.0b013e32834b9fb1","article-title":"Lipid-lowering therapy and coronary artery bypass graft surgery: what are the benefits?","volume":"26","author":"Kulik","year":"2011","journal-title":"Curr Opin Cardiol"},{"key":"R24-11-20210204","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1177\/147323000803600611","article-title":"Pre-operative atorvastatin therapy to decrease the systemic inflammatory response after coronary artery bypass grafting","volume":"36","author":"Dereli","year":"2008","journal-title":"J Int Med Res"},{"key":"R25-11-20210204","doi-asserted-by":"crossref","first-page":"E243","DOI":"10.1532\/HSF98.20091185","article-title":"The effect of statin therapy on stimulation of endothelium-derived nitric oxide before and after coronary artery bypass surgery","volume":"13","author":"Sasmazel","year":"2010","journal-title":"Heart Surg Forum"},{"key":"R26-11-20210204","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/FJC.0b013e3181c37d4d","article-title":"Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study","volume":"55","author":"Spadaccio","year":"2010","journal-title":"J Cardiovasc Pharmacol"},{"key":"R27-11-20210204","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/01.CCM.0000201407.89977.EA","article-title":"Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery","volume":"34","author":"Chello","year":"2006","journal-title":"Crit Care Med"},{"key":"R28-11-20210204","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.athoracsur.2006.10.065","article-title":"Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery","volume":"83","author":"Chello","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"R29-11-20210204","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MCA.0b013e32834b830e","article-title":"Long-term coronary artery graft patency as evaluated by 64-slice coronary computed tomographic angiography","volume":"22","author":"Levisman","year":"2011","journal-title":"Coron Artery Dis"},{"key":"R30-11-20210204","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000688","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:43:19Z","timestamp":1620960199000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00019501-201903000-00011"}},"subtitle":["analysis from the EXCEL trial"],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000000688","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}